Odense, Denmark

Klaus Baek Simonsen



Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 28(Granted Patents)


Location History:

  • Odense M, DK (2012 - 2013)
  • Odense, DK (2012 - 2017)

Company Filing History:


Years Active: 2012-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Klaus Baek Simonsen: Innovator in Pharmaceutical Chemistry

Introduction

Klaus Baek Simonsen is a prominent inventor based in Odense, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various neurological and psychiatric disorders. With a total of 5 patents to his name, Simonsen's work is recognized for its potential therapeutic applications.

Latest Patents

One of Klaus Baek Simonsen's latest patents is focused on "Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitors." This invention is directed towards compounds that inhibit the PDE9 enzyme. The patent outlines a pharmaceutical composition that includes a therapeutically effective amount of the compound along with a pharmaceutically acceptable carrier. Additionally, it provides methods for treating subjects suffering from neurodegenerative and psychiatric disorders by administering the compound.

Another notable patent involves "Isoquinolinone derivatives as NK3 antagonists." This invention presents isoquinolone derivatives that serve as NK3 antagonists, which are useful in treating conditions such as psychosis and schizophrenia. These innovations highlight Simonsen's commitment to addressing critical health challenges through his research.

Career Highlights

Klaus Baek Simonsen is currently associated with H. Lundbeck A/S, a leading global pharmaceutical company specializing in brain diseases. His work at Lundbeck has allowed him to focus on developing innovative treatments that can significantly improve the quality of life for patients with mental health disorders.

Collaborations

Throughout his career, Klaus has collaborated with several talented individuals, including Karsten Juhl and Nikolay Khanzhin. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared research goals.

Conclusion

Klaus Baek Simonsen's contributions to pharmaceutical chemistry through his patents and collaborations underscore his role as a key innovator in the field. His work continues to pave the way for new treatments that address complex neurological and psychiatric conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…